Molecular Deciphering of the ABO System as a Basis for Novel Diagnostics and Therapeutics in ABO Incompatible Transplantation

REFERENCES

• Matevossian E, Kern H, Huser N, Surgeon Yurii Voronoy (1895–1961)–a pioneer in the history of clinical transplantation: in memoriam at the 75th anniversary of the first human kidney transplantation. Transplant Int 2009;22:1132–1139.
   Web of Science ®Google Scholar
• Cook DJ, Graver B, Terasaki PI. ABO incompatibility in cadaver donor kidney allografts. Transplant Proc 1987;19:4549–4552.
   PubMed Web of Science ®Google Scholar
• Brynger H, Blohme I, Lindholm A, Transplantation of Cadaver Kidneys from Blood Group-A2 Donors. Transplant Proc 1982;14:195.
   Google Scholar
• Rydberg L, Breimer ME, Samuelsson BE, Blood group ABO-incompatible (A2 to O) kidney transplantation in human subjects: a clinical, serologic, and biochemical approach. Transplantation Proc 1987;19:4528–4537.
   PubMed Web of Science ®Google Scholar
• Alexandre GPJ, Squifflet JP, Debruyere M, Splenectomy as a Prerequisite for Successful Human Abo-Incompatible Renal-Transplantation. Transplant Proc 1985;17:138–143.
   Google Scholar
• Alexandre GP, Squifflet JP, De Bruyere M, Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transplant Proc 1987;19:4538–4542.
   PubMed Web of Science ®Google Scholar
• Squifflet J-P, De Meyer M, Malaise J, Lessons learned from ABO-incompatible living donor kidney transplantation: 20 years later. Exp Clin Transplant 2004;2:208–213.
   PubMedGoogle Scholar
• Gloor JM, Lager DJ, Moore SB, ABO-incompatible kidney transplantation using both A2 and non-A2 living donors. Transplantation 2003;75:971–977.
   PubMed Web of Science ®Google Scholar
• Slapak M, Digard N, Ahmed M, Renal transplantation across the ABO barrier–a 9-year experience. Transplant Proc 1990;22:1425–1428.
   Google Scholar
• Tanabe K, Takahashi K, Sonda K, Long-term results of ABO-incompatible living kidney transplantation: a single-center experience. Transplantation 1998;65:224–228.
   PubMed Web of Science ®Google Scholar
• Fryer JP, Benedetti E, Perry EH, Antibody-mediated rejection of an HLA-identical, ABO-incompatible kidney transplant after two failed cadaver transplants. Transplantation 1994;58:723–725.
   Google Scholar
• Hanto DW, Brunt EM, Goss JA, Accelerated acute rejection of an A2 renal allograft in an O recipient: association with an increase in anti-A2 antibodies. Transplantation 1993;56:1580–1583.
   Google Scholar
• Alexander JW, First MR, Majeski JA, The late adverse effect of splenectomy on patient survival following cadaveric renal transplantation. Transplantation 1984;37:467–470.
   Google Scholar
• Sutherland DE, Fryd DS, So SK, Long-term effect of splenectomy versus no splenectomy in renal transplant patients. Reanalysis of a randomized prospective study. Transplantation 1984;38:619–624.
   Google Scholar
• Takahashi K, Saito K, Tanabe K, First report of a 7-year survey on ABO-incompatible kidney transplantation in Japan. Clin Exp Nephrol 2001;5:119–125.
   Google Scholar
• Takahashi K, Saito K, Takahara S, Japanese ABOIKTC. Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan. Am J Transplant 2004;4:1089–1096.
   PubMed Web of Science ®Google Scholar
• Norden G, Briggs D, Cockwell P, ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment. Xenotransplantation 2006;13:148–153.
   PubMed Web of Science ®Google Scholar
• Tyden G, Kumlien G, Genberg H, ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab. Am J Transplant 2005;5:145–148.
   PubMed Web of Science ®Google Scholar
• Rydberg L, Ascher H, Krantz M, Characterization of the humoral immune response in two paediatric patients transplanted with split livers from ABO-incompatible living-related donors: appearance of cytomegalovirus-induced ABO antibodies. Transfus Med 2005;15:137–144.
   Google Scholar
• Donauer J, Wilpert J, Geyer M, ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a single center experience. Xenotransplantation 2006;13:108–110.
   Google Scholar
• Tyden G. The European experience. Transplantation 2007;84:S2–S3.
   Google Scholar
• Flint SM, Walker RG, Hogan C, Successful ABO-incompatible kidney transplantation with antibody removal and standard immunosuppression. Am J Transplant 2011;11:1016–1024.
   Google Scholar
• Saito K, Nakagawa Y, Suwa M, Pinpoint targeted immunosuppression: anti-CD20/MMF desensitization with anti-CD25 in successful ABO-incompatible kidney transplantation without splenectomy. Xenotransplantation 2006;13:111–117.
   PubMed Web of Science ®Google Scholar
• Sonnenday CJ, Warren DS, Cooper M, Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy. Am J Transplant 2004;4:1315–1322.
   PubMed Web of Science ®Google Scholar
• Gordon RD, Iwatsuki S, Esquivel CO, Liver transplantation across ABO blood groups. Surgery 1986;100:342–348.
   PubMed Web of Science ®Google Scholar
• Gugenheim J, Samuel D, Reynes M, Liver transplantation across AB0 blood group barriers. Lancet 1990;336:519–523.
   PubMed Web of Science ®Google Scholar
• Fishbein TM, Emre S, Guy SR, Safe transplantation of blood type A2 livers to blood type O recipients. Transplantation 1999;67:1071–1073.
   PubMed Web of Science ®Google Scholar
• Kluger MD, Guarrera JV, Olsen SK, Safety of blood group A2-to-O liver transplantation: an analysis of the United Network of Organ Sharing database. Transplantation 2012;94:526–531.
   PubMed Web of Science ®Google Scholar
• Skogsberg U, Breimer ME, Friman S, Successful ABO-incompatible liver transplantation using A2 donors. Transplant Proc 2006;38:2667–2670.
   PubMed Web of Science ®Google Scholar
• Banner NR, Rose ML, Cummins D, Management of an ABO-incompatible lung transplant. Am J Transplant 2004;4:1192–1196.
   Google Scholar
• Struber M, Warnecke G, Hafer C, Intentional ABO-incompatible lung transplantation. Am J Transplant 2008;8:2476–2478.
   Google Scholar
• West LJ, Pollock-Barziv SM, Dipchand AI, ABO-incompatible heart transplantation in infants. N Engl J Med 2001;344:793–800.
   PubMed Web of Science ®Google Scholar
• Biglarnia AR, Nilsson B, Nilsson T, Prompt reversal of a severe complement activation by eculizumab in a patient undergoing intentional ABO-incompatible pancreas and kidney transplantation. Transplant Int 2011;24:e61–e66.
   Google Scholar
• Daniels G. ABO, Hh and Lewis Blood Group Systems. Human blood groups. Oxford, UK: Blackwell Science Ltd; 1995.
   Google Scholar
• Economidou J, Hughes-Jones NC, Gardner B. Quantitative measurements concerning A and B antigen sites. Vox Sang 1967;12:321–328.
   PubMedGoogle Scholar
• Holgersson J, Breimer ME, Samuelsson BE. Basic biochemistry of cell surface carbohydrates and aspects of the tissue distribution of histo-blood group ABH and related glycosphingolipids. APMIS Suppl 1992;27:18–27.
   Google Scholar
• Breimer ME, Molne J, Norden G, Blood group A and B antigen expression in human kidneys correlated to A1/A2/B, Lewis, and secretor status. Transplantation 2006;82:479–485.
   PubMed Web of Science ®Google Scholar
• Breimer ME, Samuelsson BE. The specific distribution of glycolipid-based blood group A antigens in human kidney related to A1/A2, Lewis, and secretor status of single individuals. A possible molecular explanation for the successful transplantation of A2 kidneys into O recipients. Transplantation 1986;42:88–91.
   PubMed Web of Science ®Google Scholar
• Ulfvin A, Bäcker AE, Clausen H, Expression of glycolipid blood group antigens in single human kidneys: change in antigen expression of rejected ABO incompatible kidney grafts. Kidney Int 1993;44:1289–1297.
   Google Scholar
• Holgersson J, Backer AE, Breimer ME, The blood group B type-4 heptaglycosylceramide is a minor blood group B structure in human B kidneys in contrast to the corresponding A type-4 compound in A kidneys. Structural and in vitro biosynthetic studies. Biochim Biophys Acta 1992;1180:33–43.
   Google Scholar
• Klein HG, Anstee DJ. ABO, Lewis and P groups and Ii antigens. Mollison's blood transfusion in clinical medicine. 11th ed. Oxford, UK: Blackwell Publishing; 2005. pp. 114–162.
   Google Scholar
• Bryan CF, Nelson PW, Aeder MI, Current experience with renal transplantation across the ABO blood group barrier. Transplant Proc 1992;24:2527–2529.
   Google Scholar
• Shimmura H, Tanabe K, Ishikawa N, Role of anti-A/B antibody titers in results of ABO-incompatible kidney transplantation. Transplantation 2000;70:1331–1335.
   Google Scholar
• Kumlien G, Wilpert J, Safwenberg J, Comparing the tube and gel techniques for ABO antibody titration, as performed in three European centers. Transplantation 2007;84:S17–S19.
   Google Scholar
• Tanabe K. Interinstitutional variation in the measurement of anti-A/B antibodies: the Japanese ABO-Incompatible Transplantation Committee survey. Transplantation 2007;84:S13–S16.
   Google Scholar
• Tyden G, Kumlien G, Efvergren M. Present techniques for antibody removal. Transplantation 2007;84:S27–S29.
   Google Scholar
• Rydberg L, Bengtsson A, Samuelsson O, In vitro assessment of a new ABO immunosorbent with synthetic carbohydrates attached to sepharose. Transplant Int 2005;17:666–672.
   PubMed Web of Science ®Google Scholar
• Biglarnia AR, Nilsson B, Nilsson Ekdahl K, Desensitization with antigen-specific immunoadsorption interferes with complement in ABO-incompatible kidney transplantation. Transplantation 2012;93:87–92.
   Google Scholar
• Valli PV, Puga Yung G, Fehr T, Changes of circulating antibody levels induced by ABO antibody adsorption for ABO-incompatible kidney transplantation. Am J Transplant 2009;9:1072–1080.
   Google Scholar
• Mannami M, Mitsuhata N. Improved outcomes after ABO-incompatible living-donor kidney transplantation after 4 weeks of treatment with mycophenolate mofetil. Transplantation 2005;79:1756–1758.
   PubMed Web of Science ®Google Scholar
• Agishi T, Takahashi K, Ota K, Comparative evalutation of immunoadsorption and double filtration plasmapheresis for removal of anti-A or anti-B antibody in ABO-incompatible kidney transplantation. Transplant Proc 1992;24:557–558.
   PubMed Web of Science ®Google Scholar
• Rydberg L, Hallberg E, Björck S, Studies on the removal of anti-pig xenoantibodies in the human by plasmapheresis/immunoadsorption. Xenotransplantation 1995;2:253–263.
   Google Scholar
• Dorling A. Transplant accomodation - are the lessons learned from xenotransplantation pertinent for clinical allotransplantation? Am J Transplant 2012;12:545–553.
   Google Scholar
• Lynch RJ, Platt JL. Accommodation in organ transplantation. Curr Opin Organ Transplant 2008;13:165–170.
   Google Scholar
• Lynch RJ, Platt JL. Accommodation in renal transplantation: unanswered questions. Curr Opin Organ Transplant 2010;15:481–485.
   Google Scholar
• Platt JL, Vercellotti GM, Dalmasso AP, Transplantation of discordant xenografts: a review of progress. Immunol Today 1990;11:450–456.
   PubMedGoogle Scholar
• Alkhunaizi AM, de Mattos AM, Barry JM, Renal transplantation across the ABO barrier using A2 kidneys. Transplantation 1999;67:1319–1324.
   Google Scholar
• Nelson PW, Landreneau MD, Luger AM, Ten-year experience in transplantation of A2 kidneys into B and O recipients. Transplantation 1998;65:256–260.
   Google Scholar
• Sorensen JB, Grant WJ, Belnap LP, Transplantation of ABO group A2 kidneys from living donors into group O and B recipients. Am J Transplant 2001;1:296–299.
   Google Scholar
• Gloor JM, Lager DJ, Fidler ME, A Comparison of splenectomy versus intensive posttransplant antidonor blood group antibody monitoring without splenectomy in ABO-incompatible kidney transplantation. Transplantation 2005;80:1572–1577.
   Google Scholar
• Ishida H, Koyama I, Sawada T, Anti-AB titer changes in patients with ABO incompatibility after living related kidney transplantations: survey of 101 cases to determine whether splenectomies are necessary for successful transplantation. Transplantation 2000;70:681–685.
   Google Scholar
• Genberg H, Hansson A, Wernerson A, Pharmacodynamics of rituximab in kidney allotransplantation. Am J Transplant 2006;6:2418–2428.
   PubMed Web of Science ®Google Scholar
• Tyden G, Genberg H, Tollemar J, A randomized, doubleblind, placebo-controlled, study of single-dose rituximab as induction in renal transplantation. Transplantation 2009;87:1325–1329.
   PubMed Web of Science ®Google Scholar
• Vieira CA, Agarwal A, Book BK, Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics. Transplantation 2004;77:542–548.
   PubMed Web of Science ®Google Scholar
• Segev DL, Simpkins CE, Warren DS, ABO incompatible high-titer renal transplantation without splenectomy or anti-CD20 treatment. Am J Transplant 2005;5:2570–2575.
   PubMed Web of Science ®Google Scholar
• Montgomery RA. Renal transplantation across HLA and ABO antibody barriers: integrating paired donation into desensitization protocols. Am J Transplant 2010;10:449–457.
   PubMed Web of Science ®Google Scholar
• Jordan SC, Tyan D, Stablein D, Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial. J Am Soc Nephrol 2004;15:3256–3262.
   PubMed Web of Science ®Google Scholar
• Alachkar N, Lonze BE, Zachary AA, Infusion of high-dose intravenous immunoglobulin fails to lower the strength of human leukocyte antigen antibodies in highly sensitized patients. Transplantation 2012;94:165–171.
   PubMed Web of Science ®Google Scholar
• Pins MR, Saidman SL, Cosimi AB, Accelerated acute rejection of an apparent A2 renal allograft in an O recipient: report of a case with flow cytometric analysis. Transplantation 1997;63:984–988.
   Google Scholar
• Rydberg L, Breimer ME, Brynger H, ABO-incompatible kidney transplantation (A2 to O). Qualitative and semiquantitative studies of the humoral immune response against different blood group A antigens. Transplantation 1990;49:954–960.
   Google Scholar
• Montgomery JR, Berger JC, Warren DS, Outcomes of ABO-incompatible kidney transplantation in the United States. Transplantation 2012;93:603–609.
   PubMed Web of Science ®Google Scholar
• Slapak M, Naik RB, Lee HA. Renal transplant in a patient with major donor-recipient blood group incompatibility: reversal of acute rejection by the use of modified plasmapheresis. Transplantation 1981;31:4–7.
   Google Scholar
• Mohacsi P, Rieben R, Sigurdsson G, Successful management of a B-type cardiac allograft into an O-type man with 3(1/2)-year clinical follow-up. Transplantation 2001;72:1328–1330.
   Google Scholar
• Pierson RN, 3rd, Loyd JE, Goodwin A, Successful management of an ABO-mismatched lung allograft using antigen-specific immunoadsorption, complement inhibition, and immunomodulatory therapy. Transplantation 2002;74:79–84.
   PubMed Web of Science ®Google Scholar
• Mierzejewska B, Durlik M, Lisik W, Current approaches in national kidney paired donation programs. Ann Transplant 2013;18:112–124.
   PubMedGoogle Scholar
• Wallis CB, Samy KP, Roth AE, Kidney paired donation. Nephrol Dial Transplant 2011;26:2091–2099.
   Google Scholar
• Ferrari P, Hughes PD, Cohney SJ, ABO-incompatible matching significantly enhances transplant rates in kidney paired donation. Transplantation 2013;96:821–826.
   PubMed Web of Science ®Google Scholar
• Clausen H, Hakomori S. ABH and related histo-blood group antigens; immunochemical differences in carrier isotypes and their distribution. Vox Sang 1989;56:1–20.
   PubMed Web of Science ®Google Scholar
• Kobata A, Ginsburg V. Oligosaccharides of human milk. I. Isolation and characterization. Arch Biochem Biophys 1969;130:509–513.
   Google Scholar
• Lundblad A, Hallgren P, Rudmark A, Structures and serological activities of three oligosaccharides isolated from urines of nonstarved secretors and from secretors on lactose diet. Biochemistry 1973;12:3341–3345.
   PubMed Web of Science ®Google Scholar
• Szulman AE. The histological distribution of blood group A and B substances in man. J Exp Med 1960;111:785–800.
   PubMed Web of Science ®Google Scholar
• Watkins W. The ABO blood group system, historical background. Transfus Med 2001;11:243–265.
   PubMed Web of Science ®Google Scholar
• Varki A, Cummings RD, Esko JD, et al. Editors. Essentials of glycobiology. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 2009.
   Google Scholar
• de Graffenried CL, Bertozzi CR. The roles of enzyme localization and complex formation in glycan assembly within the Golgi apparatus. Curr Opin Cell Bio 2004;16:356–363.
   PubMed Web of Science ®Google Scholar
• Tu L, Banfield DK. Localization of Golgi-resident glycosyltransferases. Cell Mol Life Sci 2010;67:29–41.
   Google Scholar
• Finne J. Identification of the blood-group ABH-active glycoprotein components of human erythrocyte membrane. Eur J Biochem 1980;104:181–189.
   PubMedGoogle Scholar
• Fredriksson SA, Podbielska M, Nilsson B, ABH blood group antigens in N-glycan of human glycophorin A. Arch Biochem Biophys 2010;498:127–135.
   Google Scholar
• Podbielska M, Fredriksson SA, Nilsson B. ABH blood group antigens in O-glycans of human glycophorin A. Arch Biochem Biophys 2004;429:145–153.
   Google Scholar
• Matsui T, Titani K. ABO(H) blood group expression on circulating glycoproteins. Methods Mol Med 1998;9:235–245.
   Google Scholar
• Bryne M, Lilleholt S, Thrane PS, Distribution of blood-group-related carbohydrate antigens on oral endothelial cells. Histochem J 1993;25:339–347.
   Google Scholar
• Gehrie EA, Cates JM, Nian H, Blood Group A antigen expression on cardiac endothelium is highly individualized: possible implications for transplantation. Cardiovasc Pathol 2013;22:251–256.
   Google Scholar
• Ravn V, Dabelsteen E. Tissue distribution of histo-blood group antigens. APMIS 2000;108:1–28.
   PubMed Web of Science ®Google Scholar
• Tasaki M, Yoshida Y, Miyamoto M, Identification and characterization of major proteins carrying ABO blood group antigens in the human kidney. Transplantation 2009;87:1125–1133.
   Google Scholar
• Kelly RJ, Rouquier S, Giorgi D, Sequence and expression of a candidate for the human Secretor blood group alpha(1,2)fucosyltransferase gene (FUT2). Homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor phenotype. J Biol Chem 1995;270:4640–4649.
   PubMed Web of Science ®Google Scholar
• Larsen RD, Ernst LK, Nair RP, Molecular cloning, sequence, and expression of a human GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase cDNA that can form the H blood group antigen. Proc Natl Acad Sci USA 1990;87:6674–6678.
   PubMed Web of Science ®Google Scholar
• Rouquier S, Lowe JB, Kelly RJ, Molecular cloning of a human genomic region containing the H blood group alpha(1,2)fucosyltransferase gene and two H locus-related DNA restriction fragments. Isolation of a candidate for the human Secretor blood group locus. J Biol Chem 1995;270:4632–4639.
   Google Scholar
• Yamamoto F, Clausen H, White T, Molecular genetic basis of the histo-blood group ABO system. Nature 1990;345:229–233.
   PubMed Web of Science ®Google Scholar
• Yamamoto F, NcNeill PD, Hakomori S. Human histo-blood group A2 transferase coded by A2 allele, one of the A subtypes, is characterized by a single base deletion in the coding sequence, which results in an additional domain at the carboxyl terminal. Biochem Biophys Res Commun 1992;187:366–374.
   Google Scholar
• Amado M, Almeida R, Schwientek T, Clausen H. Identification and characterization of large galactosyltransferase gene families: galactosyltransferases for all functions. Biochim Biophys Acta 1999;1473:35–53.
   PubMed Web of Science ®Google Scholar
• Hennet T. The galactosyltransferase family. Cell Mol Life Sci 2002;59:1081–1095.
   PubMed Web of Science ®Google Scholar
• Togayachi A, Sato T, Narimatsu H. Comprehensive enzymatic characterization of glycosyltranferases with a b3GT or b4GT motif. Methods Enzymol 2006;416:91–101.
   Google Scholar
• Holgersson J, Lofling J. Glycosyltransferases involved in type 1 chain and Lewis antigen biosynthesis exhibit glycan and core chain specificity. Glycobiology 2006l;16:584–593.
   PubMed Web of Science ®Google Scholar
• Zhou D, Henion T, Jungalwala FB, The b1,3-galactosyltransferase b3GalT-V is a stage-specific embryonic antigen-3 (SSEA-3) synthase. J Biol Chem 2000;275:22631–22634.
   Google Scholar
• Yang Z, Bergstrom J, Karlsson KA. Glycoproteins with Gal alpha 4Gal are absent from human erythrocyte membranes, indicating that glycolipids are the sole carriers of blood group P activities. J Biol Chem 1994;269:14620–14624.
   Google Scholar
• Ju T, Brewer K, D'Souza A, Cloning and expression of human core 1 b1,3galactosyltransferase. J Biol Chem 2002;277:178–186.
   PubMedGoogle Scholar
• Ly M, Laremore TN, Linhardt RJ. Proteoglycomics: recent progress and future challenges. OMICS 2010;14:389–399.
   PubMed Web of Science ®Google Scholar
• Osman N, McKenzie IFC, Mouhtouris E, MS. Switching amino-terminal cytoplasmic domains of a(1,2)fucosyltransferase and a(1,3)galactosyltransferase alters the expression of H substance and Gala(1,3)Gal. J Biol Chem 1996;271:33105–33109.
   PubMed Web of Science ®Google Scholar
• Deutscher SL, Nuwayhid N, Stanley P, Translocation across Golgi vesicel membranes: a CHO glycosylation mutant deficient in CMP-sialic acid transport. Cell 1984;39:295–299.
   PubMed Web of Science ®Google Scholar
• Svensson L, Hult AK, Stamps R, Forssman expression on human erythrocytes: biochemical and genetic evidence of a new histo-blood group system. Blood 2013;121:1459–1468.
   Google Scholar
• Oriol R, Le Pendu J, Mollicone R. Genetics of ABO, H, Lewis, X and related antigens. Vox Sang 1986;51:161–171.
   PubMed Web of Science ®Google Scholar
• Gillard BK, Jones MA, Marcus DM. Glycosphingolipids of human umbilical vein endothelial cells and smooth muscle cells. Arch Biochem Biophys 1987;256:435–445.
   PubMed Web of Science ®Google Scholar
• Gillard BK, Jones MA, Turner AA, Interferon-g alters expression of endothelial cell-surface glycosphingolipids. Arch Biochem Biophys 1990;279:122–129.
   Google Scholar
• Nosaka M, Ishida Y, Tanaka A, Aberrant expression of histo-blood group A type 3 antigens in vascular endothelial cells in inflammatory sites. J Histochem Cytochem 2008;56:223–231.
   Google Scholar
• Mikhalski D, Wissing KM, Ghisdal L, Cold ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression. Transplantation 2008;85:S3–S9.
   Google Scholar
• Bjork S, Breimer ME, Hansson GC, Structures of blood group glycosphingolipids of human small intestine. A relation between the expression of fucolipids of epithelial cells and the ABO, Le and Se phenotype of the donor. J Biol Chem 1987;262:6758–6765.
   Web of Science ®Google Scholar
• Finne J, Breimer ME, Hansson GC, Novel polyfucosylated N-linked glycopeptides with blood group A, H, X, and Y determinants from human small intestinal epithelial cells. J Biol Chem 1989;264:5720–5735.
   Google Scholar
• Holgersson J, Jovall PA, Samuelsson BE, Blood group type glycosphingolipids of human kidneys. Structural characterization of extended globo-series compounds. Glycoconj J 1991;8:424–433.
   Google Scholar
• Hayashi S, Noguchi K, Yagihashi A, Expression of blood group antigen (A,B,H, Lea,Leb) on liver allografts. Transplant Proc 1992;24:2567–2568.
   Google Scholar
• Samuelsson BE, Magnusson S, Rydberg L, Structural characterization of blood group A glycolipids in blood group A liver tissue in situ perfused with O blood: the dominating presence of type 1 core chain A antigens. Xenotransplantation 2006;13:160–165.
   Google Scholar
• Kumasaki T, Yoshida A. Biochemical evidence that secretor gene, Se, is a structural gene encoding a specific fucosyltransferase. Proc Natl Acad Sci USA 1984;81:4193–4197.
   Google Scholar
• Oriol R, Danilovs J, Hawkins BR. A new genetic model proposing that the Se gene is a structural gene closely linked to the H gene. Am J Hum Gen 1981;33:421–431.
   PubMedGoogle Scholar
• Thorpe SJ, Hunt B, Yacoub M. Expression of ABH blood group antigens in human heart tissue and its relevance to cardiac transplantation. Transplantation 1991;51:1290–1295.
   Google Scholar
• Breimer ME. Tissue specificity of glycosphingolipids as expressed in pancreas and small intestine of blood group A and B human individuals. Arch Biochem Biophys 1984;228:71–85.
   Google Scholar
• Ernst C, Thurin J, Atkinson B, Monoclonal antibody localization of A and B isoantigens in normal and malignant fixed human tissues. Am J Pathol 1984;117:451–461.
   Google Scholar
• Ito N, Nishi K, Kawahara S, Difference in the ability of blood group-specific lectins and monoclonal antibodies to recognize the ABH antigens in human tissues. Histochem J 1990;22:604–614.
   Google Scholar
• Ito N, Nishi K, Nakajima M, Histochemical localization and analysis of blood group-related antigens in human pancreas using immunostaining with monoclonal antibodies and exoglycosidase digestion. J Histochem Cytochem 1990;38:1331–1340.
   Google Scholar
• Rieben R, Buchs JP, Fluckiger E, Antibodies to histo-blood group substances A and B: agglutination titers, Ig class, and IgG subclasses in healthy persons of different age categories. Transfusion 1991;31:607–615.
   Google Scholar
• Springer GF, Williamson P, Readler BL. Blood group active gram-negative bacteria and higher plants. Ann N Y Acad Sci 1962;97:104–110.
   Google Scholar
• Springer GF. Influenza virus vaccine and blood group A-like substances. Transfusion 1963;3:233–236.
   Google Scholar
• Rydberg L, Breimer ME, Holgersson J, Characterisation of the anti-A antibody response following an ABO incompatible (A2 to O) kidney transplantation. Mol Immunol 1992;29:547–560.
   PubMed Web of Science ®Google Scholar
• Rydberg L, Nyberg G, Attman PO, Characterization of the anti-A antibody binding in an ABO-incompatible living donor renal transplantation. Nephrol Dial Transplant 1994;9:1162–1165.
   Google Scholar
• Lindberg L, Johansson SM, Liu J, Is there a clinical need for a diagnostic test allowing detection of chain type-specific anti-A and anti-B? Transfusion 2011;51:494–503.
   Google Scholar
• Lindberg L, Theinert K, Liu J, Adsorption of chain type-specific ABO antibodies on Sepharose-linked A and B tetrasaccharides. Transfusion 2012;52:2356–2367.
   Google Scholar
• Kumlien G, Ullstrom L, Losvall A, Clinical experience with a new apheresis filter that specifically depletes ABO blood group antibodies. Transfusion 2006;46:1568–1575.
   PubMed Web of Science ®Google Scholar
• Chopek MW, Simmons RL, Platt JL. ABO-incompatible renal transplantation: initial immunopathologic evaluation. Transplant Proc 1987;19:4553–4557.
   PubMed Web of Science ®Google Scholar
• Bach FH, Ferran C, Hechenleitner P, Accommodation of vascularized xenografts: Expression of “protective genes” by donor endothelial cells in a host Th2 cytokine environment. Nature Med 1997;3:196–204.
   PubMed Web of Science ®Google Scholar
• Ding JW, Zhou T, Ma L, Expression of complement regulatory proteins in accommodated xenografts induced by anti-a-Gal IgG1 in a rat-to-mouse model. Am J Transplant 2008;8:32–40.
   Google Scholar
• Dalmasso AP, Benson BA, Johnson JS, Resistance against the membrane attack complex of complement induced in porcine endothelial cells with a Gala(1–3)Gal binding lectin: upregulation of CD59 expression. J Immunol 2000;164:3764–3773.
   Google Scholar
• Salama AD, Delikouras A, Pusey CD, Transplant accommodation in highly sensitized patients: a potential role for Bcl-xL and alloantibody. Am J Transplant 2001;1:260–269.
   PubMedGoogle Scholar
• Park WD, Grande JP, Ninova D, Accommodation in ABO-incompatible kidney allografts, a novel mechanism of self-protection against antibody-mediated injury. Am J Transplant 2003;3:952–960.
   Google Scholar
• Medawar PB. Transplantation of tissues and organs: introduction. Br Med Bull 1965;21:97–99.
   Google Scholar
• Koestner SC, Kappeler A, Schaffner T, Histo-blood group change of the graft from B to O after ABO mismatched heart transplantation. Lancet 2004;363:1523–1525.
   Google Scholar
• Lagaaij EL, Cramer-Knijnenburg GF, van Kemenade FJ, Endothelial cell chimerism after renal transplantation and vascular rejection. Lancet 2001;357:33–37.
   PubMedGoogle Scholar
• Tanabe T, Ishida H, Horita S, Endothelial chimerism after ABO-incompatible kidney transplantation. Transplantation 2012;93:709–716.
   Google Scholar
• Yu PB, Holzknecht ZE, Bruno D, Modulation of natural IgM binding and complement activation by natural IgG antibodies: a role for IgG anti-Gal alpha1–3Gal antibodies. J Immunol 1996;157:5163–5168.
   Google Scholar
• Krishnan NS, Fleetwood P, Higgins RM, Application of flow cytometry to monitor antibody levels in AB0 incompatible kidney transplantation. Transplantation 2008;86:474–477.
   Google Scholar
• Stussi G, Huggel K, Lutz HU, Isotype-specific detection of ABO blood group antibodies using a novel flow cytometric method. Br J Haematol 2005;130:954–963.
   Google Scholar
• Yurugi K, Kimura S, Ashihara E, Rapid and accurate measurement of anti-A/B IgG antibody in AB0-unmatched living donor liver transplantation by surface plasmon resonance. Transfus Med 2007;17:97–106.
   Google Scholar
• Frame T, Carroll T, Korchagina E, Synthetic glycolipid modification of red blood cell membranes. Transfusion 2007;47:876–882.
   Google Scholar
• Hult AK, Frame T, Chesla S, Flow cytometry evaluation of red blood cells mimicking naturally occurring ABO subgroups after modification with variable amounts of function-spacer-lipid A and B constructs. Transfusion 2012;52:247–251.
   Google Scholar
• Matic G, Hofmann D, Winkler R, Removal of immunoglobulins by a protein A versus an antihuman immunoglobulin G-based system: evaluation of 602 sessions of extracorporeal immunoadsorption. Artif Organs 2000;24:103–107.
   PubMed Web of Science ®Google Scholar
• Bensinger WI, Baker DA, Buckner CD, Immunoadsorption for removal of A and B blood-group antibodies. N Engl J Med 1981;304:160–162.
   PubMed Web of Science ®Google Scholar
• Bannett AD, Bensinger WI, Raja R, Immunoadsorption and renal transplant in two patients with a major ABO incompatibility. Transplantation 1987;43:909–911.
   Google Scholar
• Mendez R, Sakhrani L, Aswad S, Successful living-related ABO incompatible renal transplant using the BIOSYNSORB immunoadsorption column. Transplant Proc 1992;24:1738–1740.
   Google Scholar
• Blomberg L, Bratt T, Chester MA, Improved removal of anti-A and anti-B antibodies from plasma using blood-group-active haptens. Vox Sang 1993;65:126–135.
   Google Scholar
• Rieben R, Korchagina EY, von Allmen E, In vitro evaluation of the efficacy and biocompatibility of new, synthetic ABO immunoabsorbents. Transplantation 1995;60:425–430.
   Google Scholar
• Solovan JC, Oh HI, Alikhani A, Synthetic blood group antigens for anti-A removal device and their interaction with monoclonal anti-A IgM. Transplant Immunol 2006;16:245–249.
   Google Scholar
• Genberg H, Kumlien G, Wennberg L, The efficacy of antigen-specific immunoadsorption and rebound of anti-A/B antibodies in ABO-incompatible kidney transplantation. Nephrol Dial Transplant 2011;26:2394–2400.
   PubMed Web of Science ®Google Scholar
• Genberg H, Kumlien G, Wennberg L, Isoagglutinin adsorption in ABO-incompatible transplantation. Transfus Apher Sci 2010;43:231–235.
   Google Scholar
• McKane W, Lee J, Preston R, Polymorphism in the human anti-pig natural antibody repertoire. Implications for antigen-specific immunoadsorption. Transplantation 1998;66:626–633.
   PubMedGoogle Scholar
• Lofling JC, Hauzenberger E, Holgersson J. Absorption of anti-blood group A antibodies on P-selectin glycoprotein ligand-1/immunoglobulin chimeras carrying blood group A determinants: core saccharide chain specificity of the Se and H gene encoded alpha1,2 fucosyltransferases in different host cells. Glycobiology 2002;12:173–182.
   PubMed Web of Science ®Google Scholar
• Lindberg L, Liu J, Holgersson J. Engineering of therapeutic and diagnostic o-glycans on recombinant mucin-type immunoglobulin fusion proteins expressed in CHO cells. In: Beck A, editor. Glycosylation engineering of biopharmaceuticals: methods and protocols, methods in molecular biology. New York: Springer Science+Business Media; 2013. 988, pp. 3–17.
   Google Scholar
• Romano EL, Soyano A, Linares J, Neutralization of ABO blood group antibodies by specific oligosaccharides. Transplant Proc 1987;19:4426–4430.
   Google Scholar
• Romano EL, Soyano A, Montano RF, Treatment of ABO hemolytic disease with synthetic blood group trisaccharides. Vox Sang 1994;66:194–199.
   Google Scholar
• Oliver C, Blake D, Henry S. In vivo neutralization of anti-A and successful transfusion of A antigen-incompatible red blood cells in an animal model. Transfusion 2011;51:2664–2675.
   Google Scholar
• Simon PM, Neethling FA, Taniguchi S, Intravenous infusion of Galalpha1–3Gal oligosaccharides in baboons delays hyperacute rejection of porcine heart xenografts. Transplantation 1998;65:346–353.
   PubMed Web of Science ®Google Scholar
• Ye Y, Neethling FA, Niekrasz M, Evidence that intravenously administered alpha-galactosyl carbohydrates reduce baboon serum cytotoxicity to pig kidney cells (PK15) and transplanted pig hearts. Transplantation 1994;58:330–337.
   PubMed Web of Science ®Google Scholar
• Diamond LE, Byrne GW, Schwarz A, Analysis of the control of the anti-gal immune response in a non-human primate by galactose alpha1–3 galactose trisaccharide-polyethylene glycol conjugate. Transplantation 2002;73:1780–1787.
   PubMed Web of Science ®Google Scholar
• Katopodis AG, Warner RG, Duthaler RO, Removal of anti-Galalpha1,3Gal xenoantibodies with an injectable polymer. J Clin Invest 2002;110:1869–1877.
   Google Scholar
• Teranishi K, Gollackner B, Buhler L, Depletion of anti-gal antibodies in baboons by intravenous therapy with bovine serum albumin conjugated to gal oligosaccharides. Transplantation 2002;73:129–139.
   Google Scholar